Literature DB >> 943571

Polypeptides of mumps virus.

S C Jensik, S Silver.   

Abstract

Mumps virus was propagated in the extra-embryonic fluids of embryonated chicken eggs and was labeled by cionjection of radioactively labeled amino acids. The virus was purified by density gradient centrifugation, and its polypeptides were analyzed by polyarylamide gel electrophoresis. The virus was found to be composed of six polypeptides, ranging in size from 40,000 to 64,000 daltons. Viral proteins 1 and 3 were the glycoproteins of the virons. When the virus particle was treated with noniontic detergents, a small fraction of these glycoproteins could be released into the supernatant. After treatment with nonionic detergents in high salt and alkaline conditions, more of the surface glycoproteins were removed. This treatment also released the smallest viral polypeptide from the virion. The glycoproteins were separated using an affinity chromatographic column of agarose-fetuin. The heavier glycoprotein, viral protein 1, was found to contain both the neuraminidase and hemagglutinating activity. The two glycoproteins were tested for their ability to react in complement-fixing tests with mumps antisera. Only the heavier glycoprotein reacted with antisera possessing both anti-S and anti-V activity. Neither glycoprotein reacted with antisera specific for the S antigen. Thus, it was concluded that this glycoprotein corresponds to the classical V antigen of mumps virus.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 943571      PMCID: PMC515427     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  Two kinds of myxovirus.

Authors:  A P WATERSON
Journal:  Nature       Date:  1962-03-24       Impact factor: 49.962

2.  Application of a microtechnique to viral serological investigations.

Authors:  J L SEVER
Journal:  J Immunol       Date:  1962-03       Impact factor: 5.422

3.  Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids.

Authors:  D AMINOFF
Journal:  Biochem J       Date:  1961-11       Impact factor: 3.857

4.  Mumps virus.

Authors:  K CANTELL
Journal:  Adv Virus Res       Date:  1961       Impact factor: 9.937

5.  A short description of the Myxovirus group (influenza and related viruses).

Authors:  C H ANDREWES; F B BANG; F M BURNET
Journal:  Virology       Date:  1955-07       Impact factor: 3.616

6.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

7.  Parainfluenza virus surface projections: glycoproteins with haemagglutinin and neuraminidase activities.

Authors:  C Chen; R W Compans; P W Choppin
Journal:  J Gen Virol       Date:  1971-04       Impact factor: 3.891

8.  Isolation of paramyxovirus glycoproteins. Association of both hemagglutinating and neuraminidase activities with the larger SV5 glycoprotein.

Authors:  A Scheid; L A Caliguiri; R W Compans; P W Choppin
Journal:  Virology       Date:  1972-12       Impact factor: 3.616

9.  RNA polymerase in mumps virion.

Authors:  J P Bernard; R L Northrop
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

10.  Mumps virus replication in chick embryo lung cells: properties of ribonucleic acids in virions and infected cells.

Authors:  J L East; D W Kingsbury
Journal:  J Virol       Date:  1971-08       Impact factor: 5.103

View more
  12 in total

1.  Hemagglutinin-neuraminidase glycoprotein as a determinant of pathogenicity in mumps virus hamster encephalitis: analysis of mutants selected with monoclonal antibodies.

Authors:  A Löve; R Rydbeck; K Kristensson; C Orvell; E Norrby
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

2.  Protective effects of glycoprotein-specific monoclonal antibodies on the course of experimental mumps virus meningoencephalitis.

Authors:  J S Wolinsky; M N Waxham; A C Server
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

3.  Selective inactivation of hemagglutinin and neuraminidase on mumps virus.

Authors:  R Leprat; M Aymard
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

Review 4.  [Mumps vaccines: virological basis].

Authors:  A Ströhle; D Germann
Journal:  Soz Praventivmed       Date:  1995

5.  Polypeptides of respiratory syncytial virus.

Authors:  S Levine
Journal:  J Virol       Date:  1977-01       Impact factor: 5.103

6.  Differentiation of mumps virus strains with monoclonal antibody to the HN glycoprotein.

Authors:  A C Server; D C Merz; M N Waxham; J S Wolinsky
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

7.  Polypeptide composition of mumps virus.

Authors:  H I Huppertz; W W Hall; V ter Meulen
Journal:  Med Microbiol Immunol       Date:  1977-12-27       Impact factor: 3.402

8.  Enzyme-linked immunosorbent assay for mumps and parainfluenza type 1 immunoglobulin G and immunoglobulin M antibodies.

Authors:  P Ukkonen; O Väisänen; K Penttinen
Journal:  J Clin Microbiol       Date:  1980-04       Impact factor: 5.948

9.  Rapid diagnosis of acute mumps infection by a direct immunoglobulin M antibody capture enzyme immunoassay with labeled antigen.

Authors:  J P Gut; C Spiess; S Schmitt; A Kirn
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

Review 10.  Application of Oral Fluid Assays in Support of Mumps, Rubella and Varicella Control Programs.

Authors:  Peter A C Maple
Journal:  Vaccines (Basel)       Date:  2015-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.